SB398 makes broad changes to Nevada’s health insurance prior authorization rules and autism coverage requirements. For private health carriers, the bill shortens decision timelines for prior authorization, requires more detailed public procedures and clinical review criteria, limits when approvals can be revoked, bars denials for services that were not subject to prior authorization at the time care was provided, and requires stronger appeal protections, including review by appropriately specialized physicians or dentists. It also adds special rules for emergency services, certain pain medications for terminal conditions, mental health and substance use disorder care, prescription drug electronic submissions, and provider exemptions from prior authorization when a carrier has approved at least 80 percent of that provider’s requests for a service in the prior year.
The bill also expands autism spectrum disorder coverage across multiple insurance categories, including individual and group health plans, nonprofit hospital and medical or dental service corporations, health maintenance organizations, fraternal benefit societies, managed care organizations, and certain self-insured public and private plans. It raises the covered age limit for autism-related screening, diagnosis, and treatment from under 18, or under 22 if still in high school, to under 27, removes the annual $72,000 cap on applied behavior analysis, and eliminates several prior limitations and exclusions. In addition, it prohibits insurers from considering a person’s eligibility for Medicaid, Medicare, Social Security benefits, or other governmental health-related programs when determining coverage or payment, and it extends similar prior authorization reforms to Medicaid and CHIP administration.
SB398 would significantly affect Nevada insurance statutes by amending multiple chapters of NRS and adding new sections governing private insurers, Medicaid, CHIP, and public employee coverage. It requires insurers and the Department of Health and Human Services to publish annual prior authorization data, including approval rates, appeal outcomes, processing times, use of artificial intelligence, and certain surgical procedure data. It also makes conflicting contract terms void and unenforceable, and it sets an effective date of January 1, 2026 for most provisions, with earlier effectiveness only for administrative preparation and rulemaking.
Because there are no committee transcripts or recorded votes in the provided materials, there is no documented legislative debate or recorded sentiment to summarize. Based on the bill text alone, the measure appears strongly consumer- and patient-protective, with an emphasis on transparency, faster utilization review, continuity of care, and expanded autism coverage. The fiscal note indicates possible local government impact and a state fiscal impact, and the bill also contains an unfunded mandate, suggesting potential cost concerns for insurers, public programs, and local government plans.
The main points of likely contention are the bill’s cost and administrative burden versus its patient-access goals. Insurers and plan administrators may object to the shortened turnaround times, mandatory specialist review, public reporting requirements, provider exemption rules, and limits on revoking approvals or denying claims. Supporters would likely emphasize reduced delays in care, fewer unnecessary prior authorization barriers, stronger protections for autism services and mental health treatment, and greater transparency in coverage decisions.
SB398 would amend Nevada insurance law across private coverage, public employee plans, Medicaid, and CHIP by imposing new prior authorization standards, expanding autism spectrum disorder benefits, and prohibiting insurers from using a person’s access to Medicaid, Medicare, Social Security, or other governmental health programs as a factor in coverage or payment decisions. It also creates new reporting, website disclosure, and appeal requirements, and it makes conflicting policy terms unenforceable. The bill would apply to most new or renewed coverage beginning January 1, 2026, and would require the Department of Health and Human Services and insurers to adopt compliant procedures before that date.
No committee transcript or vote history was provided, so there is no recorded public sentiment to summarize from legislative debate. The bill’s structure and findings suggest a generally pro-consumer, pro-patient approach focused on reducing prior authorization delays, expanding autism coverage, and improving transparency. At the same time, the fiscal note and unfunded mandate language indicate that implementation costs and administrative complexity are likely to be concerns for insurers, public programs, and local government plans.
The likely areas of contention are the bill’s operational and financial impact on insurers and public programs. Opponents may focus on the compressed 24- and 48-hour prior authorization deadlines, mandatory specialist review, automatic approval remedies for violations, annual reporting obligations, and the 80 percent provider exemption rule. They may also object to the expanded autism coverage age limit and removal of the annual benefit cap. Supporters are likely to argue that these changes are necessary to prevent care delays, improve continuity of treatment, and reduce administrative barriers for patients and providers.